cyclo(alanylalanyl) has been researched along with rucaparib in 1 studies
| Studies (cyclo(alanylalanyl)) | Trials (cyclo(alanylalanyl)) | Recent Studies (post-2010) (cyclo(alanylalanyl)) | Studies (rucaparib) | Trials (rucaparib) | Recent Studies (post-2010) (rucaparib) |
|---|---|---|---|---|---|
| 5 | 0 | 3 | 236 | 36 | 220 |
| Protein | Taxonomy | cyclo(alanylalanyl) (IC50) | rucaparib (IC50) |
|---|---|---|---|
| Poly [ADP-ribose] polymerase tankyrase-1 | Homo sapiens (human) | 0.0847 | |
| Poly [ADP-ribose] polymerase 1 | Homo sapiens (human) | 0.0418 | |
| Protein mono-ADP-ribosyltransferase PARP14 | Homo sapiens (human) | 8.8713 | |
| Protein mono-ADP-ribosyltransferase PARP10 | Homo sapiens (human) | 1.4333 | |
| Protein mono-ADP-ribosyltransferase PARP12 | Homo sapiens (human) | 6.6285 | |
| Poly [ADP-ribose] polymerase tankyrase-2 | Homo sapiens (human) | 0.4523 | |
| Poly [ADP-ribose] polymerase 2 | Homo sapiens (human) | 0.0497 | |
| Protein mono-ADP-ribosyltransferase PARP4 | Homo sapiens (human) | 0.8354 | |
| Protein mono-ADP-ribosyltransferase PARP3 | Homo sapiens (human) | 0.4597 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jain, PG; Patel, BD | 1 |
1 review(s) available for cyclo(alanylalanyl) and rucaparib
| Article | Year |
|---|---|
Medicinal chemistry approaches of poly ADP-Ribose polymerase 1 (PARP1) inhibitors as anticancer agents - A recent update.
Topics: Animals; Antineoplastic Agents; Chemistry, Pharmaceutical; Humans; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Structure-Activity Relationship | 2019 |